BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9131147)

  • 1. Effect of SM-12502 on disseminated intravascular coagulation (DIC) in tumor-bearing rats.
    Morooka S; Natsume Y
    Adv Exp Med Biol; 1996; 416():189-93. PubMed ID: 9131147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC).
    Imanishi N; Komuro Y; Morooka S
    Lipids; 1991 Dec; 26(12):1391-5. PubMed ID: 1819739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988.
    Imura Y; Terashita Z; Nishikawa K
    Life Sci; 1986 Jul; 39(2):111-7. PubMed ID: 3741541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
    Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
    Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC.
    Ono S; Tamakuma S; Mochizuki H; Kinoshita M; Ohkusa Y; Aosasa S; Oda Y; Ohe H
    Surg Today; 1993; 23(3):228-33. PubMed ID: 8467174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery.
    Ono S; Mochizuki H; Tamakuma S
    Am J Surg; 1996 Apr; 171(4):409-15. PubMed ID: 8604832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel platelet activating factor antagonist, SM-12502, attenuates endotoxin-induced disseminated intravascular coagulation and acute pulmonary vascular injury by inhibiting TNF production in rats.
    Murakami K; Okajima K; Uchiba M; Johno M; Okabe H; Takatsuki K
    Thromb Haemost; 1996 Jun; 75(6):965-70. PubMed ID: 8822594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure.
    Ou MC; Kambayashi J; Kawasaki T; Uemura Y; Shinozaki K; Shiba E; Sakon M; Yukawa M; Mori T
    Thromb Res; 1994 Feb; 73(3-4):227-38. PubMed ID: 8191415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats.
    Yun-Choi HS; Pyo MK; Chang KC; Lee DH
    Planta Med; 2002 Apr; 68(4):326-9. PubMed ID: 11988856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Fujita M; Izutani W; Komurasaki Y
    Thromb Haemost; 2000 Jul; 84(1):54-8. PubMed ID: 10928470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of disseminated intravascular coagulation (DIC) in active systemic anaphylaxis: role of platelet-activating factor.
    Choi IH; Ha TY; Lee DG; Park JS; Lee JH; Park YM; Lee HK
    Clin Exp Immunol; 1995 Jun; 100(3):390-4. PubMed ID: 7774047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulation.
    Yokota Y; Inamura N; Asano M; Yamamoto Y; Nakahara K; Notsu Y; Ono T; Watanabe M
    Eur J Pharmacol; 1994 Jun; 258(3):239-46. PubMed ID: 8088357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of two tetrahydroisoquinolines (YS-49 and YS-51) on experimental disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Pyo MK; Yun-Choi HS; Chang KC; Lee DH
    Arzneimittelforschung; 2004; 54(11):705-10. PubMed ID: 15612611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between endothelin and the pathophysiology of tissue factor-induced and lipopolysaccharide-induced disseminated intravascular coagulation in rats: a study examining the effect of an endothelin receptor antagonist.
    Suga Y; Asakura H; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Nakao S; Miyamoto K
    Blood Coagul Fibrinolysis; 2004 Oct; 15(7):593-8. PubMed ID: 15389127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental model of disseminated intravascular coagulation induced by sustained infusion of endotoxin.
    Yoshikawa T; Furukawa Y; Murakami M; Takemura S; Kondo M
    Res Exp Med (Berl); 1981; 179(3):223-8. PubMed ID: 7323452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary protein C inhibitor as a therapeutic agent to disseminated intravascular coagulation (DIC): a comparison with low molecular weight heparin in rats with lipopolysaccharide-induced DIC.
    Izutani W; Fujita M; Nishizawa K; Koga J
    Biol Pharm Bull; 2000 Sep; 23(9):1046-50. PubMed ID: 10993202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].
    Lu X; Li W; Wang G; Wang Q; Jiang Y; Gao J; Zhao X; Xu L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):92-6. PubMed ID: 25665605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Asakura H; Takahashi Y; Kubo A; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Takami A; Yoshida T; Miyamoto K; Nakao S
    Crit Care Med; 2006 Sep; 34(9):2421-5. PubMed ID: 16810104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental studies on the relation of platelet activating factor (PAF) to high mortality in sublethal endotoxemia after massive hepatectomy and effects of its antagonist].
    Onuki Y; Nakamura S; Muro H; Baba S
    Nihon Geka Gakkai Zasshi; 1993 May; 94(5):466-74. PubMed ID: 8332121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats.
    Albert DH; Luo G; Magoc TJ; Tapang P; Holms JH; Davidsen SK; Summers JB; Carter GW
    Shock; 1996 Aug; 6(2):112-7. PubMed ID: 8856845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.